Two studies from ESMO have potentially found treatments which can improve survival in HR-positive breast cancer.
MYC-rearrangement within 2 years after diagnosis may affect the prognosis of patients with diffuse large B-cell lymphoma.
A new study looks into whether disease stage at diagnosis affects the occurrence and location of a second primary malignancy in DLBCL.
Researchers examined whether cancer or treatment type impacted the symptom burden of survivors of cancer.
The ACHIEVE study is one of six that are part of a global collaborative effort to evaluate the noninferiority of 3-month vs 6-month oxaliplatin-based adjuvant chemotherapy in patients with stage III colon cancer.
A new study looked at median overall survival for patients with prior antibiotic therapy compared with patients with no prior antibiotic therapy.
A new study evaluated whether the m7-FLIPI score in patients with follicular lymphoma treated with rituximab without chemotherapy can indicate prognosis.
Researchers conducted a study to determine if low levels of immune infiltration were associated with inferior outcomes among patients with follicular lymphoma.
Data from a new study show the importance of taking preventative measures against contracting human papillomavirus, including urging patients to get the HPV vaccine.
Researchers assessed whether patients with head and neck cancer who had higher levels of tumor-infiltrating lymphocytes had better survival rates.